Skip to main content
BioNxt Solutions Inc. logo

BioNxt Solutions Inc. — Investor Relations & Filings

Ticker · BNXT ISIN · CA0909741062 LEI · 254900VZ478Z39V2NM18 CSE Manufacturing
Filings indexed 244 across all filing types
Latest filing 2023-04-18 Regulatory Filings
Country CA Canada
Listing CSE BNXT

About BioNxt Solutions Inc.

https://bionxt.com/

BioNxt Solutions Inc. is a clinical-stage bioscience company focused on developing next-generation drug formulations and advanced delivery systems. The company specializes in high-performance solutions, including sublingual thin films and transdermal patches, designed to enhance bioavailability and patient compliance across critical therapeutic areas. BioNxt's R&D pipeline targets neurology, immunology, oncology, and mental health. Core platforms include advanced drug delivery systems for chronic diseases, a targeted chemotherapy platform designed to reduce systemic toxicity by delivering cytotoxic agents directly to tumors, and a proprietary library of engineered psychedelic compounds for neurological and psychiatric conditions. The company also develops diagnostic screening tests and active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-04-18 English
News release - English.pdf
Regulatory Filings
2023-04-15 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2023-04-13 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-04-13 English
Annual MD&A - English.pdf
Regulatory Filings
2023-04-13 English
Audited annual financial statements – English.pdf
Regulatory Filings
2023-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.